BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8477820)

  • 1. Molecular biology of insulin resistance.
    Müller-Wieland D; Streicher R; Siemeister G; Krone W
    Exp Clin Endocrinol; 1993; 101(1):17-29. PubMed ID: 8477820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus.
    Stefanović V; Antić S
    Clin Lab; 2004; 50(5-6):271-8. PubMed ID: 15209435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Insulin receptor and diabetes].
    Clauser E
    Rev Prat; 1994 May; 44(9):1154-62. PubMed ID: 7939336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of insulin action at the cellular level.
    Lönnroth P
    J Intern Med Suppl; 1991; 735():23-9. PubMed ID: 2043221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Insulin signaling: mechanisms altered in insulin resistance].
    Capeau J
    Med Sci (Paris); 2005 Dec; 21 Spec No():34-9. PubMed ID: 16598903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Insulin resistance: from clinical diagnosis to molecular genetics. Implications in diabetes mellitus].
    Jaffiol C; Rouard M; Macari F; Lautier C; Ait el Mkadem S; Méchaly I; Brun JF; Renard E; Cros G; Bringer J; Grigorescu F
    Bull Acad Natl Med; 1999; 183(9):1761-75; discussion 1775-7. PubMed ID: 10987057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guanine nucleotide binding regulatory proteins in liver from obese humans with and without type II diabetes: evidence for altered "cross-talk" between the insulin receptor and Gi-proteins.
    Caro JF; Raju MS; Caro M; Lynch CJ; Poulos J; Exton JH; Thakkar JK
    J Cell Biochem; 1994 Mar; 54(3):309-19. PubMed ID: 8200911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Insulin resistance. Receptor and post-receptor abnormalities].
    Liguori M; Urso R; Fatigante G
    Minerva Endocrinol; 1998 Jun; 23(2):37-52. PubMed ID: 9844354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Insulin receptors: structure and physiology].
    Canivet B; Jullien D; Sadoul JL; Freychet P
    Rev Prat; 1992 Jun; 42(11):1400-5. PubMed ID: 1529256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein tyrosine phosphatase regulation in fibroblasts from patients with an insulin receptor gene mutation.
    Seki N; Yagi S; Suzuki Y; Shimada F; Taira M; Makino H; Amano K; Yagui K; Saito Y; Hashimoto N
    Horm Metab Res; 2008 Dec; 40(12):833-7. PubMed ID: 18925540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of insulin action in normal and insulin-resistant states.
    Le Marchand-Brustel Y
    Exp Clin Endocrinol Diabetes; 1999; 107(2):126-32. PubMed ID: 10320053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of insulin action.
    Combettes-Souverain M; Issad T
    Diabetes Metab; 1998 Dec; 24(6):477-89. PubMed ID: 9932214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The brown adipose cell: a model for understanding the molecular mechanisms of insulin resistance.
    Valverde AM; Benito M; Lorenzo M
    Acta Physiol Scand; 2005 Jan; 183(1):59-73. PubMed ID: 15654920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin receptor kinase defects as a possible cause of cellular insulin resistance.
    Häring H; Obermaier B; Ermel B; Su Z; Mushack J; Rattenhuber E; Hölzl J; Kirsch D; Machicao F; Herberg L
    Diabete Metab; 1987 Jul; 13(3 Pt 2):284-93. PubMed ID: 2820811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An arginine to cysteine(252) mutation in insulin receptors from a patient with severe insulin resistance inhibits receptor internalisation but preserves signalling events.
    Hamer I; Foti M; Emkey R; Cordier-Bussat M; Philippe J; De Meyts P; Maeder C; Kahn CR; Carpentier JL
    Diabetologia; 2002 May; 45(5):657-67. PubMed ID: 12107746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Insulin resistance and arterial hypertension].
    Weidmann P; Müller-Wieland D; de Courten M; Krone W
    Herz; 1995 Feb; 20(1):16-32. PubMed ID: 7713473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the actin cytoskeleton in insulin action.
    Tsakiridis T; Tong P; Matthews B; Tsiani E; Bilan PJ; Klip A; Downey GP
    Microsc Res Tech; 1999 Oct; 47(2):79-92. PubMed ID: 10523787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential biological mechanisms of arsenic-induced diabetes mellitus.
    Tseng CH
    Toxicol Appl Pharmacol; 2004 Jun; 197(2):67-83. PubMed ID: 15163543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.